Home › Asset managers › Compare 2023-2024 › Brighthouse vs Jackson National
Note on Brighthouse: its funds did not all vote the same way on 11.4% of the 112,275 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
Brighthouse 2023-2024 · Jackson National 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 17,897 | 13,062 | 712 | 4,123 | 94.8% | 85.9% |
| Board proposals | 14,879 | 10,895 | 668 | 3,316 | 94.2% | 86.0% |
| E&S shareholder proposals | 328 | 30 | 5 | 293 | 85.7% | 42.5% |
| Other items | 2,690 | 2,137 | 39 | 514 | 98.2% | 90.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
712 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Brighthouse | Jackson National |
|---|---|---|---|---|---|---|
| XENON PHARMACEUTICALS INC. | June 4, 2024 | Compensation of Named Executive Officers: Approve, on an advisory basis, the compensation of the Corporations named executive officers Say-on-Pay |
Board | For | ABSTAIN 2 funds |
FOR 3 funds |
| XENON PHARMACEUTICALS INC. | June 4, 2024 | Remuneration of Auditor: Authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditor of the Corporation Audit-related |
Board | For | ABSTAIN 2 funds |
FOR 3 funds |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | Election of Directors: Johan Wedell-Wedellsborg Director Elections |
Board | For | WITHHOLD 4 funds |
ABSTAIN 1 fund |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | Election of Directors: Michael Rossi Director Elections |
Board | For | FOR 4 funds |
ABSTAIN 1 fund |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | Election of Directors: Thomas Gad Director Elections |
Board | For | WITHHOLD 4 funds |
ABSTAIN 1 fund |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | To approve, on a non-binding advisory vote basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| YEXT INC. | June 12, 2024 | Election of Class I Directors: Evan Skorpen Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 2 funds |
| YEXT INC. | June 12, 2024 | Election of Class I Directors: Julie Richardson Director Elections |
Board | For | WITHHOLD 2 funds |
ABSTAIN 2 funds |
| ZIPRECRUITER INC. | June 11, 2024 | Election of Class III Directors for three-year term: Blake Irving Director Elections |
Board | For | WITHHOLD 1 fund |
ABSTAIN 1 fund |
| ZIPRECRUITER INC. | June 11, 2024 | Election of Class III Directors for three-year term: Emily McEvilly Director Elections |
Board | For | WITHHOLD 1 fund |
ABSTAIN 1 fund |
| ZOOMINFO TECHNOLOGIES INC. | May 15, 2024 | To elect the director nominees listed in the Proxy Statement: Henry Schuck Director Elections |
Board | For | WITHHOLD 8 funds |
ABSTAIN 6 funds |
| ZOOMINFO TECHNOLOGIES INC. | May 15, 2024 | To elect the director nominees listed in the Proxy Statement: Keith Enright Director Elections |
Board | For | WITHHOLD 8 funds |
ABSTAIN 6 funds |
← Previous Page 8 of 8
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.